Insider transactions

Michael C Macdonald

CIK 1207400 · Exec Chairman of the Board · last filed 2020-10-02

Michael C Macdonald is an Exec Chairman of the Board who has filed 42 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider sold $826.9K of MED on Oct 2, 2020. Across all open-market trades the lifetime net is −$9.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions. 18 SEC filings were submitted jointly with XEROX CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$3.67M
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$9.43M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MED price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O MEDIFAST, INC.
3600 CRONDALL LANE
OWINGS MILLS, MD 21117
Related Filers
XEROX CORP — 18 joint filings, latest 2007-05-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MED Director 280,802 $12.97 $3.64M -$8.47M 26 2020-10-02
PAETEC Holding Corp. (PAET) Delisted Director 0 — — $0 9 2011-12-02
MAPLEBY HOLDINGS MERGER Corp (OMX) Delisted EVP and President, Contract 0 — — $0 2 2011-11-04
XRX Senior Vice President 26,906 $0.92 $24.6K -$955.5K 4 2007-05-02

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
MED Direct 271,002 96.5% 2020-10-02
Michael C
Michael C. MacDonald Charitable Remainder Unitrust
 9,800 3.5% 2019-05-28
Total 280,802
XRX Direct 20,872 77.6% 2007-05-02
Xerox Stock Fund 4,412 16.4% 2007-05-02
Employee Stock Ownership Plan 1,605 6.0% 2007-05-02
Children 17 0.1% 2007-05-02
Total 26,906

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2020-10-02 MED Sell (S) −5,000 -$826.9K EDGAR
2020-07-06 MED Sell (S) −5,000 -$694.2K EDGAR
2020-06-18 MED Grant (A) +1,083 $0 EDGAR
2020-05-08 MED Sell (S) −10,000 -$1.01M EDGAR
2019-05-28 MED Gift (G) — $0 EDGAR
2019-04-12 MED Gift (G) −1,175 $0 EDGAR
2019-03-07 MED Sell (S) −18,825 -$2.47M EDGAR
2019-02-26 MED Grant (A) +708 $0 EDGAR
2018-03-13 MED Sell (S) −40,000 -$3.47M EDGAR
2018-02-09 MED Mixed −13,920 -$1.06M EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).